Outcomes of long-term central venous access devices in pulmonary arterial hypertension: A 10-year case series
The Journal of Vascular Access · 2026-11 · 27 (6) · 2544-2552
DOI: 10.1177/11297298261457766 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Vascular Access, online erschienen am 23.06.2026. Verfasst von Juan Gómez-Sandoval und 4 weiteren Autor:innen. Beteiligte Einrichtung: Fundación Cardioinfantil - Instituto de Cardiología, Bogotá, Colombia. Die Arbeit nennt 28 Literaturangaben.
Abstract (Originalsprache)
Introduction
Continuous prostacyclin infusion is the standard of care for pulmonary arterial hypertension, requiring central venous access devices where dwell time is critical but associated with complications.
Methods
Retrospective 10-year case series of 18 adult pulmonary arterial hypertension patients managed through central venous access devices by a specialized multidisciplinary team.
Results
Sixty-nine catheters were analyzed across 18 patients; median catheter survival estimated by the Kaplan-Meier method was 9.3 months (95% confidence interval (8.1–12)). Occlusion was the most frequent complication (1.20 per 1,000 catheter-days) and the leading removal reason across all device types. Catheter-related bloodstream infections occurred in four instances (0.22 per 1,000 catheter-days), with methicillin-susceptible Staphylococcus aureus as the only isolated pathogen. Catheter-related thrombosis was documented in two cases. Three catheters fractured, one of each device type.
Discussion
Evidence on central venous access device outcomes in pulmonary arterial hypertension remains scarce in middle-income countries. The median dwell time observed in this series was shorter than that reported in high-income country cohorts, while catheter-related bloodstream infection and thrombosis rates were numerically lower than those documented in comparable series.
Conclusion
In this descriptive 10-year case series from a middle-income country, long-term central venous access devices for continuous epoprostenol infusion in pulmonary arterial hypertension were associated with a prolonged dwell time and low complication rates under a structured multidisciplinary follow-up model. Larger multicenter studies are needed to confirm generalizability and identify determinants of catheter longevity.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Fundación Cardioinfantil - Instituto de Cardiología, Bogotá, Colombia.
- Fundación Neumológica Colombiana Pulmonary Vascular Disease Program NeumoVasc Rexpira, Bogotá, Colombia.
ORCID-Profile: Juan Gómez-Sandoval, Valeria Correa-Martinez, Carlos F Román-Ortega
Zitieren
APA
Gómez-Sandoval, J., Correa-Martinez, V., Amaya-Nieto, J., Conde-Camacho, R., & Román-Ortega, C. F. (2026). Outcomes of long-term central venous access devices in pulmonary arterial hypertension: A 10-year case series. The Journal of Vascular Access, 27(6), 2544-2552. https://doi.org/10.1177/11297298261457766
Vancouver
Gómez-Sandoval J, Correa-Martinez V, Amaya-Nieto J, Conde-Camacho R, Román-Ortega CF. Outcomes of long-term central venous access devices in pulmonary arterial hypertension: A 10-year case series. The Journal of Vascular Access. 2026;27(6):2544-2552. doi:10.1177/11297298261457766
BibTeX
@article{GmezSandoval2026,
author = {Gómez-Sandoval, Juan and Correa-Martinez, Valeria and Amaya-Nieto, Javier and Conde-Camacho, Rafael and Román-Ortega, Carlos F},
title = {Outcomes of long-term central venous access devices in pulmonary arterial hypertension: A 10-year case series},
journal = {The Journal of Vascular Access},
year = {2026},
volume = {27},
number = {6},
pages = {2544--2552},
doi = {10.1177/11297298261457766}
}
EUVIMED